Results 191 to 200 of about 20,735 (212)
ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates [PDF]
Lancet, The, 2021 Elizabeth T Rogawski Mcquade
exaly +3 more sources
Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination
New England Journal of Medicine, 2021 Heterologous Vaccination with ChAdOx1 nCoV-19 and mRNA-1273 Health care workers who had received a dose of ChAdOx1 nCoV-19 were offered a choice of receiving either ChAdOx1 nCoV-19 or mRNA-1273 9 t...
Johan Normark +2 more
exaly +3 more sources
ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 [PDF]
Lancet, The, 2020 Chauhan, Anil +3 more
exaly +6 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
ChAdOx1 S (recombinant) vaccine: thrombosis and thrombocytopenia
Drug and Therapeutics Bulletin, 2021Abstract Overview of: Case reports from five patients in Norway and 11 patients from Germany and Austria.
openaire +2 more sources
Sweet syndrome following the ChAdOx1-S vaccine
BMJ Case ReportsWe report a case of vaccine-induced Sweet syndrome in a female patient in her 50s presenting with fevers and a scattered red patchy rash on the lower limbs. Seven days prior, she had received the first dose of AstraZeneca ChAdOx1-S vaccine. A skin biopsy confirmed Sweet syndrome.
Olivia Baker +3 more
openaire +2 more sources
Thrombosis with Thrombocytopenia Syndrome after ChAdOx1 nCoV-19 vaccination
Rinsho Shinkeigaku, 2022A 48-year-old Japanese man who had no previous medical history received his first dose of the ChAdOx1 nCoV-19 vaccine. Ten days after the vaccine administration, he developed a headache. Laboratory results indicated throm-bocytopenia and DIC. A head CT revealed microbleeding in the left parietal lobe.
Mari, Takatsuki +5 more
openaire +2 more sources